GGHC
TDOC icon

Gilder Gagnon Howe & Co’s Teladoc Health TDOC Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-870,804
Closed -$62.8M – 276
2022
Q1 		$62.8M Sell
870,804
-69,925
-7% -$5.04M 0.58% 49
2021
Q4 		$86.4M Sell
940,729
-58,019
-6% -$6.93M 0.49% 66
2021
Q3 		$127M Sell
998,748
-41,999
-4% -$6.11M 0.66% 50
2021
Q2 		$173M Sell
1,040,747
-184,001
-15% -$29.8M 0.85% 34
2021
Q1 		$223M Sell
1,224,748
-160,324
-12% -$37.2M 1.2% 20
2020
Q4 		$277M Buy
1,385,072
+532,749
+63% +$108M 1.37% 16
2020
Q3 		$187M Sell
852,323
-92,645
-10% -$19.6M 1.15% 19
2020
Q2 		$180M Sell
944,968
-113,163
-11% -$19.8M 1.41% 15
2020
Q1 		$164M Sell
1,058,131
-122,695
-10% -$14.3M 1.97% 10
2019
Q4 		$98.9M Sell
1,180,826
-138,213
-10% -$10.5M 1.03% 26
2019
Q3 		$89.3M Sell
1,319,039
-17,608
-1% -$1.16M 1.02% 33
2019
Q2 		$88.8M Sell
1,336,647
-143,012
-10% -$8.34M 0.9% 39
2019
Q1 		$82.3M Sell
1,479,659
-33,802
-2% -$2.06M 0.88% 41
2018
Q4 		$75M Buy
1,513,461
+12,245
+0.8% +$749K 1.06% 29
2018
Q3 		$130M Buy
1,501,216
+23,940
+2% +$1.71M 1.32% 19
2018
Q2 		$85.8M Buy
1,477,276
+83,319
+6% +$4.07M 0.92% 35
2018
Q1 		$56.2M Buy
1,393,957
+38,532
+3% +$1.45M 0.7% 43
2017
Q4 		$47.2M Buy
1,355,425
+216,848
+19% +$7.2M 0.63% 50
2017
Q3 		$37.7M Buy
1,138,577
+1,005,239
+754% +$33M 0.53% 60
2017
Q2 		$4.63M Buy
133,338
+132,212
+11,742% +$3.85M 0.07% 152
2017
Q1 		$28K Hold
1,126
– – ﹤0.01% 272
2016
Q4 		$19K Sell
1,126
-16
-1% -$272 ﹤0.01% 262
2016
Q3 		$21K Sell
1,142
-67,048
-98% -$1.18M ﹤0.01% 267
2016
Q2 		$1.09M Sell
68,190
-56,066
-45% -$654K 0.02% 183
2016
Q1 		$1.19M Sell
124,256
-524
-0.4% -$7.44K 0.02% 163
2015
Q4 		$2.24M Buy
124,780
+6,774
+6% +$125K 0.04% 157
2015
Q3 		$2.63M Buy
+118,006
New +$3.19M 0.04% 158

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Gilder Gagnon Howe & Co's TDOC Position: Q2 2022 in Review

Gilder Gagnon Howe & Co sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 870,804 shares — an estimated $62.8M sold.

Gilder Gagnon Howe & Co first reported a position in TDOC in Q3 2015 and held it in 27 quarters. The position peaked at $277M in Q4 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Gilder Gagnon Howe & Co reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 870,804 Teladoc Health shares in Q2 2022, an estimated $62.8M.
  • Gilder Gagnon Howe & Co first reported a position in Teladoc Health in Q3 2015 and held it in 27 quarters.
  • Gilder Gagnon Howe & Co's Teladoc Health position peaked at $277M in Q4 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2022, filed 15 Aug 2022.